Trials / Unknown
UnknownNCT04477369
Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers
An Exploratory Clinical Trial to Compare and Evaluate Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Adult Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to explore the differences in pharmacokinetics and safety characteristics between Test Drugs(DWJ1439, DWJ1464) and that of Reference Drugs(DWC202003, DWC202004) in healthy adults.
Detailed description
The purpose of this study is to explore the differences in pharmacokinetics and safety characteristics between Test Drugs(DWJ1439, DWJ1464) and that of Reference Drugs(DWC202003, DWC202004) in healthy adults with fasting state: Randomized, open-label, oral, single-dose, four-treatment, three-period, non-replicated crossover study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWJ1439 | 300mg single dose |
| DRUG | DWJ1464 | 300mg single dose |
| DRUG | DWC202003 | 300mg single dose |
| DRUG | DWC202004 | 300mg single dose |
Timeline
- Start date
- 2020-08-06
- Primary completion
- 2020-08-31
- Completion
- 2020-09-01
- First posted
- 2020-07-20
- Last updated
- 2020-07-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04477369. Inclusion in this directory is not an endorsement.